Day OneTuesday, 9 December 2025 - CST/CDT (Central Daylight, GMT-5)

See how AI is being used to streamline prior authorization and unlock predictive analytics.

Understand practical applications across payer, provider, and health tech sectors.

Explore ethical, legal, and privacy challenges surrounding large-scale automation in pharmacy.

Learn from companies actively deploying AI tools in clinical and administrative workflows.

Explore the clinical promise and payer pressure surrounding GLP-1 drugs.

Understand the pricing dynamics, access limitations, and formulary decisions impacting patients.

Examine real-world plan design strategies for balancing innovation with affordability.

Navigate the complex patchwork of regulations across all 50 states—an increasingly impossible challenge for PBMs and stakeholders to track effectively alongside ongoing multi-state litigation.

Assess how states like Arkansas and Indiana are challenging the traditional PBM model through vertical integration regulation, with updates on the ongoing CVS/Arkansas litigation.

Learn how states are driving healthcare regulation faster than federal bodies, impacting PBM contract terms, transparency requirements, and GPO usage.

Explore the financial trade-offs between keeping healthcare costs manageable while meeting increasingly expansive coverage requirements.

Gain insight into the fallout from FTC litigation against PBMs.

Explore how antitrust action could reshape pricing, biosimilar strategies, and PBM contract models.

Examine how digital health startups are transforming care coordination and pharmacy workflows.

Understand how point solutions are integrating—or conflicting—with PBM ecosystems, with a focus on interoperability challenges and opportunities.

Explore real-world contracting models involving digital-first vendors and how interoperability impacts their success.

Explore how PBM and health plan contracts influence specialty pharmacy access, pricing, and performance.

Examine the impact of vertical integration on patient choice, competition, and transparency.

Discuss regulatory scrutiny, steering practices, and implications for independent specialty pharmacies.

Learn how emerging PBMs are restructuring rebate flows, networks, and data transparency.

Explore how disruptor PBMs are offering employers more accountable and transparent alternatives to traditional contract structures.

Hear case studies from disruptor PBMs successfully scaling innovative approaches within regulated environments.

Review biosimilar adoption trends and payer-driven barriers across therapy classes.

Examine reimbursement challenges and provider hesitancy compared to traditional generics.

Discuss market dynamics, contracting strategies, and downstream effects on patient access and provider behavior.

Explore how AFPs, pharmaceutical companies, and self-insured employers are approaching the challenge of rising specialty drug costs.

Understand the compliance, access, and ethical considerations as programs intersect with patient assistance resources.

Hear multiple perspectives on the impact of redirecting limited free-drug programs and the implications for patients and plan sponsors.

Explore how stakeholders are working to make rebate flows and PBM contract terms more transparent and easier to interpret.

Hear how real-world data is being used to simplify pharmacy benefit decisions for employers, patients, and policymakers.

Learn about tools and strategies that break down complex rebate and performance data into accessible formats